Per a post only yesterday… The weekly chart seems to think that 84 is a reasonable target, assuming that the stock market stays stable through our projected late Aug./1st half of Sept. quiet period (as da boyz settles back in). Silly me, thinking it would take days or weeks to get to the sell target. The weekly chart in yesterday’s post projected an eventual rise … Continue reading 3rd Profit Booked in Gilead
This ‘+’ update is being sent to the entire list because it has macro market elements in it pertaining to the Biotech sector and its leadership vs. Nasdaq 100. The daily chart of GILD is pretty cut and dry. A rise above the 200 day moving average would break it above the short-term consolidation/downtrend and the pattern would measure to around 124. Here is the … Continue reading NFTRH+ Trade Setup; GILD & Biotech Sector
Gilead (GILD) has hit the target laid out in this NFTRH+ post from April. As I often do, I sold below the target but for the record, it’s a very successful trade that is now officially closed out. That doesn’t mean it won’t go higher. It probably will. Here’s the weekly chart from the original post, which also included a daily chart as well. Subscribe … Continue reading NFTRH+; GILD Hits Target
NFTRH has been talking about a ‘trade the swings’ mentality on the US stock market since probably last September or so. The swings have been routine, if very pronounced. So I am not an investor in the US stock market, although certain items have been traded personally and highlighted as NFTRH+ setups along the way. These are items with good technical setups. A couple of … Continue reading NFTRH+; SIMO & GILD
